BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1450467)

  • 1. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal clearances.
    Nolph KD
    J Lab Clin Med; 1979 Oct; 94(4):519-25. PubMed ID: 479663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-weekly hemodialysis helps continuous ambulatory peritoneal dialysis patients who have insufficient solute removal.
    Kanno Y; Suzuki H; Nakamoto H; Okada H; Sugahara S
    Adv Perit Dial; 2003; 19():143-7. PubMed ID: 14763051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New directions in peritoneal dialysis concepts and applications.
    Nolph KD; Miller F; Rubin J; Popovich R
    Kidney Int Suppl; 1980 Sep; 10():S111-6. PubMed ID: 6934332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the daily dialysate drain volume required in CAPD for a target peritoneal creatinine clearance by body water and peritoneal transport characteristics.
    Rao P; Tzamaloukas AH; Murata GH; Piraino B; Malhotra D; Bernardini J; Oreopoulos DG
    Adv Perit Dial; 1997; 13():33-7. PubMed ID: 9360647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prescription of peritoneal dialysis.
    Tzamaloukas AH; Raj DS; Onime A; Servilla KS; Vanderjagt DJ; Murata GH
    Semin Dial; 2008; 21(3):250-7. PubMed ID: 18248525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-solute clearances in diabetic subjects on continuous ambulatory peritoneal dialysis: comparison to nondiabetic subjects.
    Tzamaloukas AH; Murata GH; Malhotra D; Rao P; Piraino B; Bernardini J; Oreopoulos DG
    Adv Perit Dial; 1999; 15():179-82. PubMed ID: 10682098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
    Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
    Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis adequacy indices for peritoneal dialysis and hemodialysis.
    Debowska M; Waniewski J; Lindholm B
    Adv Perit Dial; 2005; 21():94-7. PubMed ID: 16686294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
    Tzamaloukas AH; Malhotra D; Murata GH
    ASAIO J; 1998; 44(6):828-34. PubMed ID: 9831093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.